Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Inclusion Criteria: * Age ≥ 18 years * Glaucoma diagnosis (H40. \*) with abnormal visual field as measured by 30-2 Humphrey Perimetry (mean deviation \< -2.00) * Adequate IOP control (IOP \> 7 mmHg and \< 22 mmHg) by medical or surgical means measured by Goldman Applanation Tonometry for at least 3 months * Visual field progression - decrease (more negative) in MD by 1.00 dB or more when compared to prior HVF) * Refractive error ≤ 10 diopters and astigmatism ≤ 3 diopters Exclusion Criteria: * BCVA worse than 20/200 * Pt Is unable to tolerate MPOD, CS, dermal carotenoid measurement-taking procedures * Loss of IOP control requires surgical intervention * Patient already taking AREDS formula oral supplement * Patient taking medication or dietary supplements that may interact with LM ingredients * History of photosensitive epilepsy * History of penetrating ocular trauma or vitrectomy * History of ocular or orbital radiation therapy or is currently receiving chemotherapy * Women who are nursing, pregnant, or are planning pregnancy * Has a known adverse reaction (including sulfa allergy) and/or sensitivity to the study supplement or its ingredients including: N-acetyl-cysteine, acetyl-L-carnitine, L-taurine, quercetin, Co-enzyme Q-10, lutein, meso zeaxanthin, zeaxanthin, astazanthin, lycopene, alpha-lipoic acid. * Currently enrolled in an investigational drug study or has used an investigational drug within 30 days prior to recruitment. * Is planning on having ocular surgery at any time throughout the study duration, or had ocular surgery \< 3 months before enrollment * Native lens opacity ≥ grade 3 on ARLNS standard photograph * Blue light filter intraocular lens